Want to see SE:ALZCUR full AI Analyst Report?
AlzeCure Pharma AB (ALZCUR) Financial Statements
AlzeCure Pharma AB Financial Overview
AlzeCure Pharma AB's market cap is currently $882.54M. The company's EPS TTM is $-0.53; its P/E ratio is 42.87; AlzeCure Pharma AB has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -1.27M | $ -293.00K | $ -476.00K | $ -570.00K | $ -576.00K |
| Operating Income | $ -49.37M | $ -36.45M | $ -38.26M | $ -56.44M | $ -77.93M |
| EBITDA | $ -48.10M | $ -35.70M | $ -37.87M | $ -55.67M | $ -77.20M |
| Net Income | $ -47.65M | $ -35.23M | $ -37.17M | $ -56.04M | $ -77.78M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 50.34M | $ 31.50M | $ 29.10M | $ 25.58M | $ 41.74M |
| Total Assets | $ 59.04M | $ 34.44M | $ 32.00M | $ 70.84M | $ 45.65M |
| Total Debt | $ 5.12M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -45.22M | $ -31.50M | $ -29.10M | $ -25.58M | $ -41.74M |
| Total Liabilities | $ 26.12M | $ 8.25M | $ 8.23M | $ 10.35M | $ 12.67M |
| Stockholders' Equity | $ 32.92M | $ 26.18M | $ 23.77M | $ 60.48M | $ 32.97M |
| Cash Flow | |||||
| Free Cash Flow | $ -34.59M | $ -35.25M | $ 3.06M | $ -99.91M | $ -70.69M |
| Operating Cash Flow | $ -34.59M | $ -35.12M | $ 3.06M | $ -99.91M | $ -70.64M |
| Investing Cash Flow | $ 0.00 | $ -124.00K | $ 7.00K | $ 0.00 | $ -54.00K |
| Financing Cash Flow | $ 53.43M | $ 37.65M | $ 459.00K | $ 83.75M | $ 0.00 |
Currency in SEK